Candel Therapeutics grants inducement stock options for 85,900 shares to four new employees
CADL•Candel Therapeutics granted options covering 85,900 common shares to four new employees on Sept. 30, 2026, at an exercise price of $10.44 per share.
1. Option terms
The options vest 25% on the first anniversary of each employee’s start date, with the remaining 75% vesting monthly over 36 months. The awards were issued under the company’s 2025 Inducement Plan, adopted Dec. 24, 2025.
